RecruitingNot ApplicableNCT06676644

Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines

A Comparative Study on the Immunogenicity and Safety of Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in the Elderly


Sponsor

National Taiwan University Hospital

Enrollment

200 participants

Start Date

Nov 21, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

To compare the immunogenicity, cellular immune response, and safety between adjuvanted (aIIV4) and non-adjuvanted (IIV4) seasonal influenza vaccines in the Taiwanese elderly population with chronic medical conditions.


Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called adjuvanted and a drug called non-adjuvanted for people with elderly and influenza vaccines. The study is currently recruiting participants at 1 location. People eligible for this study include aged 65 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGadjuvanted

adjuvanted (aIIV4) influenza vaccine in the Taiwanses elderly with chronic medical conditions

DRUGnon-adjuvanted

non-adjuvanted (IIV4) influenza vaccine in the Taiwanses elderly with chronic medical conditions


Locations(1)

National Taiwan University Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06676644


Related Trials